Susan M Efler
Overview
Explore the profile of Susan M Efler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cooper C, Ahluwalia N, Efler S, Vollmer J, Krieg A, Davis H
J Immune Based Ther Vaccines
. 2008 Jun;
6:3.
PMID: 18541039
Background: Chronic hepatitis C virus (HCV) infection results from weak or absent T cell responses. Pegylated-interferon-alpha (IFN-alpha) and ribavirin, the standard of care for chronic HCV, have numerous immune effects...
2.
McHutchison J, Bacon B, Gordon S, Lawitz E, Shiffman M, Afdhal N, et al.
Hepatology
. 2007 Oct;
46(5):1341-9.
PMID: 17929306
Unlabelled: CPG 10101, a synthetic oligodeoxynucleotide (ODN), is a toll-like receptor 9 (TLR9) agonist with antiviral and immunomodulatory properties that could potentially influence chronic infection with HCV. In this multicenter...
3.
Vicari A, Schmalbach T, Lekstrom-Himes J, Morris M, Al-Adhami M, Laframboise C, et al.
Antivir Ther
. 2007 Aug;
12(5):741-51.
PMID: 17713157
Unlabelled: CPG 10101 (ACTILON) is a novel potent and selective unmethylated cytidine-phosphate-guanosine (CpG)-containing oligodeoxynucleotide agonist of Toll-like receptor 9 (TLR9) being developed for the treatment of chronic infections such as...
4.
Krieg A, Efler S, Wittpoth M, Al Adhami M, Davis H
J Immunother
. 2004 Nov;
27(6):460-71.
PMID: 15534490
Subcutaneous injection of normal human volunteers with a B-class CpG oligodeoxynucleotide (ODN) TLR9 agonist, CPG 7909, induced a TH1-like pattern of systemic innate immune activation manifested by expression of IL-6,...